NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc . (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company that delivers intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming Noble Capital Markets’ 20^Th Annual Emerging Growth Equity Conference on December 3-4, 2024 in Boca Raton, FL.

Noble Capital Markets’ 20^Th Annual Emerging Growth Equity Conference
Date: 3–4 December 2024
Place: Florida Atlantic University, Boca Raton, FL
Presentation day and time: Wednesday, December 4, 2024, at 2 p.m. ET
Presentation location: Presentation room 3

A link to the recording of the presentation will be available on INBS Investor Relations website two days after the incident.

Management will also be available during the event for one-on-one meetings with the investment community. To schedule a meeting, please contact your NobleCon representative or KCSA Strategic Communications via email [email protected].

About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company that delivers innovative, rapid, non-invasive testing solutions. The company believes its Intelligent Fingerprinting Drug Screening System will revolutionize wearable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the tests test for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The company’s current customer segments outside the United States include construction, manufacturing and engineering companies, transportation and logistics companies, drug treatment organizations and medical examiners.

For more information, visit:

Company contact:
Intelligent Bio Solutions Inc.
[email protected]

Contact for investors and media:
Valter Pinto, CEO
KCSA strategic communication
PH: (212) 896-1254
[email protected]